Guinea-Bissau vs Myanmar: Prevalence rate of hypertension in women aged 30-79
Guinea-Bissau
39.7
in 2019
Myanmar
40
in 2019
Guinea-Bissau rank
83rd
Myanmar rank
80th
Prevalence rate of hypertension in women aged 30-79 over time
- Guinea-Bissau
- Myanmar
How they compare
Myanmar currently reports 40 against 39.7 in Guinea-Bissau, a difference of 0.3.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Guinea-Bissau ahead.
Guinea-Bissau ranks 83rd and Myanmar ranks 80th of 195 countries.
Guinea-Bissau has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 37.58 | 31.72 | 5.86 | Guinea-Bissau |
| 2000s | 39.56 | 34.79 | 4.77 | Guinea-Bissau |
| 2010s | 40.04 | 38.55 | 1.49 | Guinea-Bissau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in women aged 30-79, Guinea-Bissau or Myanmar?
- Myanmar, at 40 against 39.7 in Guinea-Bissau as of 2019.
- What is the difference in prevalence rate of hypertension in women aged 30-79 between Guinea-Bissau and Myanmar?
- 0.3, with Myanmar ahead.
- How many years of comparable data are there for Guinea-Bissau and Myanmar?
- 30 years are reported by both, from 1990 to 2019.
- How do Guinea-Bissau and Myanmar rank globally for prevalence rate of hypertension in women aged 30-79?
- Guinea-Bissau ranks 83rd and Myanmar ranks 80th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in women aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of female population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.